MedPath

WB-EMS and Individualized Nutritional Support in Gynecological Cancer Patients

Not Applicable
Conditions
Cachexia
Gynecologic Cancer
Interventions
Other: Whole-Body Electromyostimulation (WB-EMS)
Registration Number
NCT03570242
Lead Sponsor
University of Erlangen-Nürnberg Medical School
Brief Summary

This study evaluates the effects of a 12-week whole-body electromyostimulation (WB-EMS) training combined with individualized nutritional support on body composition, muscle strength and function, quality of life, fatigue and Inflammatory status on patients with gynecological cancer undergoing palliative anti-cancer Treatment. Furthermore, this study assesses the effect of this combined therapeutic approach within a 3 to 4-week pre-operative study Intervention on the period of hospitalization in gynecological patients undergoing curative anti-cancer Treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
150
Inclusion Criteria
  • female patients with gynecological cancer undergoing palliative or curative treatment
  • 18 years and older
  • ECOG status > 2
Exclusion Criteria
  • simultaneous participation in other nutritional or exercise intervention Trials or in the past 6 months
  • acute cardiovascular events
  • use of anabolic medications
  • epilepsy
  • severe neurological diseases
  • skin lesions in the area of electrodes
  • energy active metals in body
  • pregnancy
  • acute vein thrombosis
  • rheumatic diseases
  • pregnant and nursing women
  • psychiatric disorders with doubts about legal and cognitive capacity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
WB-EMS group (curative treatment)Whole-Body Electromyostimulation (WB-EMS)physical exercise group (includes patients undergoing adjuvant treatment 3-4 weeks before surgery) receives regular WB-EMS training (2 EMS trainings per week; each session for 20 min) + individualized nutritional support (dietary advices: daily protein intake 1,2-1,5 g/kg bodyweight)
WB-EMS group (palliative treatment)Whole-Body Electromyostimulation (WB-EMS)physical exercise group (includes patients undergoing palliative Treatment) receives regular WB-EMS training (2 EMS trainings per week; each session for 20 min) + individualized nutritional support (dietary advices: daily protein intake 1,2-1,5 g/kg bodyweight)
Primary Outcome Measures
NameTimeMethod
Change in Skeletal muscle mass12 weeks (palliative treatment), 3-4 weeks (curative treatment)

Skeletal muscle mass assessed by bioelectrical impedance analysis (in kg)

Period of hospitalization3-4 week (curative treatment)

Days of Hospital stay after curative surgery

Secondary Outcome Measures
NameTimeMethod
Gastrointestinal toxicity of chemotherapy12 weeks (palliative treatment), 3-4 weeks (curative treatment)

Number of participants with treatment-related adverse events of gastrointestinal toxicity as assessed by CTCAE v4.0

Physical function - Endurance12 weeks (palliative treatment), 3-4 weeks (curative treatment)

Six-minute-walk test (walking distance in m)

Physical function - Isometric muscle strength12 weeks (palliative treatment), 3-4 weeks (curative treatment)

Hand grip strength assessed by hand dynamometer (in kg)

Physical function - Lower limb strength12 weeks (palliative treatment), 3-4 weeks (curative treatment)

30 second sit-to-stand test (number of sit-to-stand cycles)

Patient-reported performance status12 weeks (palliative treatment), 3-4 weeks (curative treatment), Total Score ranges from 0-100 with a higher score indicating better performance status

Karnofsky index

Patient-reported Quality of Life (QoL)12 weeks (palliative treatment), 3-4 weeks (curative treatment)

European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ - C30); Total score ranges from 0-100 with a higher score indicating better functioning/Quality of life or higher symptom burden

Pain score12 weeks (palliative treatment), 3-4 weeks (curative treatment)

Visual Analogue Scale (VAS); Total score ranges from 0-10 with a higher score indicating higher pain

Physical activity12 weeks (palliative treatment), 3-4 weeks (curative treatment)

International Physical Activity Questionnaire (IPAQ); Higher score indicates higher physical acitivity level

Patient-reported Fatigue12 weeks (palliative treatment), 3-4 weeks (curative treatment)

FACIT-Fatigue scale; Total score ranges from 0-52 with a higher score indicating better Quality of life/less fatigue

Depression score12 weeks (palliative treatment), 3-4 weeks (curative treatment)

Beck Depression Inventory (BDI); Total score ranges from 0-63 with higher score indicating higher depression

Inflammatory status12 weeks (palliative treatment), 3-4 weeks (curative treatment)

Analysis of serum C-reactive protein (CRP) and albumin concentrations

Trial Locations

Locations (1)

Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg

🇩🇪

Erlangen, Germany

© Copyright 2025. All Rights Reserved by MedPath